Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.
Peinert
Stefan
S
Kamel
Sarah
S
Seymour
John F
JF
Prince
H Miles
HM
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007167:Immunotherapy; D015552:Injections, Intralesional; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000276:immunology* / Q000601:surgery; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab